Canada markets closed

Marker Therapeutics, Inc. (GX1.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
3.7800-0.0600 (-1.56%)
At close: 09:24AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
466.785
Operating Expenses
Research Development
10,417
10,417
11,968
27,795
18,881
Selling General and Administrative
7,476
7,476
11,336
12,925
10,472
Total Operating Expenses
14,581
14,581
19,791
39,478
28,886
Operating Income or Loss
-14,581
-14,581
-19,791
-39,478
-28,419
Total Other Income/Expenses Net
-
-
-232.974
-2,407
31
Income Before Tax
-14,042
-14,042
-19,776
-41,879
-28,239
Income Tax Expense
3.675
3.675
0
-
-
Income from Continuing Operations
-14,046
-14,046
-19,776
-41,879
-28,706
Net Income
-8,237
-8,237
-29,931
-41,879
-28,706
Net Income available to common shareholders
-8,237
-8,237
-29,931
-41,879
-28,706
Basic EPS
-1.07
-
-3.58
-5.47
-6.10
Diluted EPS
-1.08
-
-3.58
-5.47
-6.10
Basic Average Shares
8,680
-
8,351
7,651
4,704
Diluted Average Shares
8,719
-
8,351
7,651
4,704